Loading
PB
Protea Biosciences Group, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by HOSTLER STANLEY, was filed 07 Nov 2016.
Protea Biosciences Group, Inc.: what insiders have been doing
Protea Biosciences Group, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Protea Biosciences Group, Inc. The previous disclosure was published on 4 April 2017.
Since 2016, the database holds 5 purchases and no sales by insiders of the company.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
34
Thresholds
n/a
Buy Volume
€39,777
5 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
Gross profit660.6k
Net income-13.9M
Last declaration on 4 April 2017
Declarations34 total
3,333,333 shares0Common StockSEC:0001144204-17-018876:1
400,000 shares0Common StockSEC:0001144204-17-018882:0
1,000,000 shares0Common StockSEC:0001144204-17-018872:0
6,000,000 shares0Common StockSEC:0001144204-17-018876:0
344,000 shares0Common StockSEC:0001144204-17-018869:0
16,564,248 shares0Common StockSEC:0001144204-17-018880:0
533,333 shares@ US$0.07585.7% of flowCommon StockSEC:0001140361-16-085049:0
293,333 shares@ US$0.07581.7% of flowCommon StockSEC:0001140361-16-085046:0
Canonical exit: 1 Feb 2017 (T+90)
50,000 shares@ US$0.098918.3% of flowCommon StockSEC:0001140361-16-082037:0
Canonical exit: 19 Dec 2016 (T+90)
70,000 shares@ US$0.15100.0% of flowCommon StockSEC:0001140361-16-073476:0
Canonical exit: 3 Oct 2016 (T+90)
20,000 shares@ US$0.1496.4% of flowCommon StockSEC:0001140361-16-073485:0
Canonical exit: 23 Oct 2016 (T+90)
24,000 shares@ US$0.1537.9% of flowCommon StockSEC:0001140361-16-071993:0
Canonical exit: 3 Oct 2016 (T+90)
5,700,248 shares0Common StockSEC:0001140361-16-058015:0
142,504 shares0Common StockSEC:0001140361-16-058015:1
1,712,333 shares0Common StockSEC:0001140361-16-058015:2
913,945 shares0Common StockSEC:0001140361-16-058015:3
90,910 shares0Common StockSEC:0001140361-16-058015:4
100,000 shares0Common StockSEC:0001140361-16-058015:5
363,273 shares0Common StockSEC:0001140361-16-055706:0
193,894 shares0Common StockSEC:0001140361-16-055706:1
244,456 shares0Common StockSEC:0001140361-16-055706:2
100,000 shares0Common StockSEC:0001140361-16-055706:3
165,573 shares0Common StockSEC:0001140361-16-055706:4
80,000 shares0Common StockSEC:0001140361-16-053822:0
100,000 sharesCommon StockSEC:0001140361-16-049969:0
25 of 34 declarations
About Protea Biosciences Group, Inc.
Protea Biosciences Group, Inc. is a company focused on developing bioanalytical technologies and research services. It specializes in the analysis of biomolecules for applications in biopharmaceuticals and biomedical research.
